1
|
ALQarni AS, Turnbull CD, Morrell MJ, Kelly JL. Efficacy of vibrotactile positional therapy devices on patients with positional obstructive sleep apnoea: a systematic review and meta-analysis. Thorax 2023; 78:1126-1134. [PMID: 37344178 DOI: 10.1136/thorax-2021-218402] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2022] [Accepted: 05/26/2023] [Indexed: 06/23/2023]
Abstract
INTRODUCTION Vibrotactile positional therapy (PT) devices are a new treatment modality for positional obstructive sleep apnoea (POSA). This review aimed to determine the effect of vibrotactile PT on the Apnoea Hypopnoea Index (AHI) and the percentage of time spent in the supine position (%Tsupine) in patients with POSA, compared with baseline. Secondary aims were to investigate the effect on daytime sleepiness, quality of life and sleep quality. METHODS A systematic review and meta-analysis was performed of randomised controlled trials (RCTs) and cohort studies that investigated the effect of vibrotactile PT in POSA patients. Searches were performed via MEDLINE, CENTRAL and Embase up to 29 October 2022. RESULTS 1119 studies were identified, 18 studies met the inclusion criteria (10 RCTs, 8 cohort studies). The use of vibrotactile PT significantly reduced the AHI at follow-up compared with baseline (mean difference (95% CI) -9.19 events/hour (-11.68 to -6.70); p<0.00001). The mean %Tsupine was also significantly reduced (mean difference (95% CI) -32.79% (-38.75% to -26.83%); p<0.00001). The percentage changes in the AHI and %Tsupine were 43% and 70%, respectively. Secondary outcomes were daytime sleepiness, quality of life and sleep indices. These showed minimal change, although follow-up was short. CONCLUSION Vibrotactile PT devices are effective in treating POSA; reducing both AHI and %Tsupine. The effect on sleep quality, daytime sleepiness and disease-specific quality of life was minimal. However, there were limited data and follow-up was often brief, meaning that further research is needed to determine the effect of vibrotactile PT on patient-centred outcomes. PROSPERO REGISTRATION NUMBER CRD42020188617.
Collapse
Affiliation(s)
- Abdullah S ALQarni
- National Heart and Lung Institute, Imperial College London, London, UK
- Department of Sleep and Ventilation, Royal Brompton Hospital, London, UK
- Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
| | - Chris D Turnbull
- NIHR Oxford Biomedical Research Centre, Oxford, UK
- Nuffield Department of Experimental Medicine, University of Oxford, Oxford, UK
- Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| | - Mary J Morrell
- National Heart and Lung Institute, Imperial College London, London, UK
| | - Julia L Kelly
- National Heart and Lung Institute, Imperial College London, London, UK
- Department of Sleep and Ventilation, Royal Brompton Hospital, London, UK
| |
Collapse
|
2
|
Hidalgo-Armas L, Inglés S, Vaca R, Cordero-Guevara J, Durán-Carro J, Ullate J, Rigau J, Durán-Cantolla J. Patient compliance and satisfaction with a new forehead device for positional obstructive sleep apnoea treatment: a post hoc analysis of a randomised controlled trial. BMJ Open Respir Res 2023; 10:e001503. [PMID: 37349132 PMCID: PMC10314629 DOI: 10.1136/bmjresp-2022-001503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2022] [Accepted: 06/06/2023] [Indexed: 06/24/2023] Open
Abstract
BACKGROUND The influence of body position in obstructive sleep apnoea patients is well known. A positional therapy device placed at the forehead has proven to be effective in reducing the severity of positional obstructive sleep apnoea (POSA) symptoms. The aim of the study was to evaluate patients' therapy compliance and satisfaction in the short term and mid-term. METHODS A post hoc analysis of a randomised controlled trial was conducted using an inactive device (ID) or an active device (AD) for 3 months. The primary outcomes were device usage and the percentage of patients with good compliance (defined as device use for more than 4 hours per night and more than 70% of nights per week). Secondary outcomes included time spent with head in the supine position, patient satisfaction and side effects. RESULTS The median duration of using the device was 6.9 hours in the ID group and 6.7 hours in the AD group (p=0.309), and the durations were similar throughout the follow-up period and from the first day of use. The percentage of patients with good compliance was similar and greater than 60% in both groups. The median time spent with head in the supine position was significantly lower in the AD group (2.9%) than in the ID group (12.4%) since the first day of treatment. Both groups showed satisfaction scores values above 8.5 (out of 10) in all items, while side effects were scarcely reported. CONCLUSION High device compliance was achieved in POSA patients, both in terms of device usage time and percentage of days used. Patients were highly satisfied, and the device effectively reduced the time spent with the head in the supine position from the first day of use.
Collapse
Affiliation(s)
- Laura Hidalgo-Armas
- Sleep Disorders Research Group, Bioaraba Health Research Institute, Vitoria, Spain
- Alava Mental Health Network, Osakidetza Basque Health Service, Vitoria, Spain
| | - Sandra Inglés
- Sleep Disorders Research Group, Bioaraba Health Research Institute, Vitoria, Spain
| | - Rafaela Vaca
- CIBER of Respiratory Diseases (CibeRes), ISCIII, Madrid, Spain
- Translational Research in Respiratory Medicine, IRB Lleida, Lleida, Spain
| | - José Cordero-Guevara
- Epidemiology and Public Health Research Group, Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain
| | - Joaquín Durán-Carro
- Sleep Disorders Research Group, Bioaraba Health Research Institute, Vitoria, Spain
| | - Jorge Ullate
- Sleep Disorders Research Group, Bioaraba Health Research Institute, Vitoria, Spain
| | - Jordi Rigau
- Research, Development and Innovation Director, SIBEL S.A.U, Barcelona, Spain
- Biophysics and Bioengineering Unit, School of Medicine Barcelona, University of Barcelona, Barcelona, Spain
| | - Joaquin Durán-Cantolla
- Honorific Professor of the Medicine Department, UPV/EHU School of Medicine, Vitoria, Spain
- Director of the Eduardo Anitua Medical Clinic Sleep Unit, Eduardo Anitua Medical Clinic Sleep Unit, Vitoria, Spain
| |
Collapse
|
3
|
Cerritelli L, Caranti A, Migliorelli A, Bianchi G, Stringa LM, Bonsembiante A, Cammaroto G, Pelucchi S, Vicini C. Sleep position and obstructive sleep apnea (OSA): Do we know how we sleep? A new explorative sleeping questionnaire. Sleep Breath 2022; 26:1973-1981. [DOI: 10.1007/s11325-022-02576-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2021] [Revised: 12/27/2021] [Accepted: 01/28/2022] [Indexed: 10/19/2022]
|
4
|
Ferrer-Lluis I, Castillo-Escario Y, Montserrat JM, Jané R. Enhanced Monitoring of Sleep Position in Sleep Apnea Patients: Smartphone Triaxial Accelerometry Compared with Video-Validated Position from Polysomnography. SENSORS 2021; 21:s21113689. [PMID: 34073215 PMCID: PMC8198328 DOI: 10.3390/s21113689] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/19/2021] [Revised: 05/13/2021] [Accepted: 05/20/2021] [Indexed: 12/11/2022]
Abstract
Poor sleep quality is a risk factor for multiple mental, cardiovascular, and cerebrovascular diseases. Certain sleep positions or excessive position changes can be related to some diseases and poor sleep quality. Nevertheless, sleep position is usually classified into four discrete values: supine, prone, left and right. An increase in sleep position resolution is necessary to better assess sleep position dynamics and to interpret more accurately intermediate sleep positions. This research aims to study the feasibility of smartphones as sleep position monitors by (1) developing algorithms to retrieve the sleep position angle from smartphone accelerometry; (2) monitoring the sleep position angle in patients with obstructive sleep apnea (OSA); (3) comparing the discretized sleep angle versus the four classic sleep positions obtained by the video-validated polysomnography (PSG); and (4) analyzing the presence of positional OSA (pOSA) related to its sleep angle of occurrence. Results from 19 OSA patients reveal that a higher resolution sleep position would help to better diagnose and treat patients with position-dependent diseases such as pOSA. They also show that smartphones are promising mHealth tools for enhanced position monitoring at hospitals and home, as they can provide sleep position with higher resolution than the gold-standard video-validated PSG.
Collapse
Affiliation(s)
- Ignasi Ferrer-Lluis
- Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain; (Y.C.-E.)
- Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBERBBN), 28029 Madrid, Spain
- Department of Automatic Control (ESAII), Universitat Politècnica de Catalunya-Barcelona Tech (UPC), 08028 Barcelona, Spain
- Correspondence: (I.F.-L.); (R.J.)
| | - Yolanda Castillo-Escario
- Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain; (Y.C.-E.)
- Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBERBBN), 28029 Madrid, Spain
- Department of Automatic Control (ESAII), Universitat Politècnica de Catalunya-Barcelona Tech (UPC), 08028 Barcelona, Spain
| | - Josep Maria Montserrat
- Sleep Lab, Pneumology Service, Hospital Clínic de Barcelona, 08036 Barcelona, Spain; (J.M.M.)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), 28029 Madrid, Spain
| | - Raimon Jané
- Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain; (Y.C.-E.)
- Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBERBBN), 28029 Madrid, Spain
- Department of Automatic Control (ESAII), Universitat Politècnica de Catalunya-Barcelona Tech (UPC), 08028 Barcelona, Spain
- Correspondence: (I.F.-L.); (R.J.)
| |
Collapse
|
5
|
Hidalgo Armas L, Ingles S, Vaca R, Cordero-Guevara J, Duran Carro J, Ullate J, Barbé F, Durán-Cantolla J. New forehead device in positional obstructive sleep apnoea: a randomised clinical trial. Thorax 2021; 76:930-938. [PMID: 33888576 DOI: 10.1136/thoraxjnl-2020-216167] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2020] [Revised: 01/22/2021] [Accepted: 01/25/2021] [Indexed: 11/04/2022]
Abstract
RATIONALE Approximately 60% of the patients with obstructive sleep apnoea suffer from a positional effect, and approximately 25% of these patients present events only in the supine position. OBJECTIVE To validate a new positional vibrating device and evaluate its efficacy in reducing the Apnoea-Hypopnoea Index and the total sleep time in the supine position without disturbing sleep. METHODS A total of 128 patients were recruited for this multicentre, prospective, parallel, randomised controlled trial and were distributed in three arms (general recommendations, inactive and active device). Full overnight polysomnography was performed at baseline and at 12 weeks. Anthropometric variables and sleep and quality of life questionnaires were collected at 4, 8 and 12 weeks. RESULTS The Apnoea-Hypopnoea Index decreased from 30.6 per hour to 20.4 per hour (p<0.001) in the active device (AD) group. In this group the reduction was 2.3-fold and 3.3-fold than the ones in the general recommendations (GR) and inactive device (ID) groups, respectively (p=0.014). Sleep time in supine position decreased 17.7%±26.3% in GR group (p<0.001), 13.0%±22.4% with ID group (p<0.001) and 21.0%±25.6% in the AD group (p<0.001). Furthermore, total sleep time increased significantly only in the AD group (22.1±57.5 min, p=0.016), with an increased percentage of time in the N3 (deep sleep) and N3+REM (rapid eye movement) stages, without sleep fragmentation. CONCLUSION The device was effective in reducing the Apnoea-Hypopnoea Index and time spent in the supine position also in improving sleep architecture. Therefore, the device could be a good option for the management of patients with positional obstructive sleep apnoea. TRIAL REGISTRATION DETAILS The trial was registered at www.clinicaltrials.gov (NCT03336515).
Collapse
Affiliation(s)
| | - Sandra Ingles
- BioAraba, Osakidetza-Basque Health Service, Vitoria-Gasteiz, Spain.,Sleep Unit, Osakidetza-Basque Health Service, Vitoria-Gasteiz, Spain
| | - Rafaela Vaca
- Respiratory Department, CIBERES, Madrid, Comunidad de Madrid, Spain.,Translational Research in Respiratory Medicine, IRBLLEIDA, Lleida, Spain
| | - Jose Cordero-Guevara
- Unidad de Metodología y Estadística, Osakidetza-Basque Health Service, Vitoria-Gasteiz, Spain
| | - Joaquin Duran Carro
- BioAraba, Osakidetza-Basque Health Service, Vitoria-Gasteiz, Spain.,Sleep Unit, Osakidetza-Basque Health Service, Vitoria-Gasteiz, Spain
| | - Jorge Ullate
- BioAraba, Osakidetza-Basque Health Service, Vitoria-Gasteiz, Spain.,Sleep Unit, Osakidetza-Basque Health Service, Vitoria-Gasteiz, Spain
| | - Ferran Barbé
- Respiratory Department, CIBERES, Madrid, Comunidad de Madrid, Spain.,Translational Research in Respiratory Medicine, IRBLLEIDA, Lleida, Spain
| | - Joaquin Durán-Cantolla
- BioAraba, Osakidetza-Basque Health Service, Vitoria-Gasteiz, Spain .,Sleep Unit, Osakidetza-Basque Health Service, Vitoria-Gasteiz, Spain.,Respiratory Department, CIBERES, Madrid, Comunidad de Madrid, Spain.,Unidad de Metodología y Estadística, Osakidetza-Basque Health Service, Vitoria-Gasteiz, Spain.,University of Vasque Country, Medicine Department, Pais Vasco, Spain
| | | |
Collapse
|